We are live on ! Find out more
PALI icon

Palisade Bio
PALI

9 hedge funds and large institutions have $35.5M invested in Palisade Bio in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

29% more funds holding

Funds holding: 7 → 9 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

8% less capital invested

Capital invested by funds: $38.8M → $35.5M (-$3.28M)

15% less call options, than puts

Call options by funds: $1.12M | Put options by funds: $1.31M

Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
–
Reduced
–
Closed
2
Calls
$1.12M
Puts
$1.31M
Net Calls
-$191K
Net Calls Change
-$347K

Top Buyers

Rank Fund Capital Flow
1
CS
Credit Suisse
Switzerland
+$2.18M
2
Goldman Sachs
Goldman Sachs
New York
+$2.18M
3
Millennium Management
Millennium Management
New York
+$2.18M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.18M

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$4.36M
2
State Street
State Street
Massachusetts
-$2.18M
3
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$237K
4
Charles Schwab
Charles Schwab
California
-$192K
5
TA
Teachers Advisors
New York
-$183K
Name Holding Trade Value Shares
Change 		Change in
Stake
PI
1
Putnam Investments
Massachusetts
$8.79M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$5.45M – – –
ACM
3
Alethea Capital Management
Washington
$4.15M – – –
BIT
4
BlackRock Institutional Trust
California
$1.78M – – –
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$1.72M +$2.18M +1 New
Millennium Management
6
Millennium Management
New York
$1.47M +$2.18M +1 New
Goldman Sachs
7
Goldman Sachs
New York
$1.43M +$2.18M +1 New
Northern Trust
8
Northern Trust
Illinois
$1.34M – – –
CS
9
Credit Suisse
Switzerland
$1.19M +$2.18M +1 New
JPCCM
10
J&P (China) Capital Management
China
$966K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$883K – – –
IGIM
12
I.G. Investment Management
Manitoba, Canada
$768K – – –
AIG
13
American International Group
New York
$428K – – –
BFA
14
BlackRock Fund Advisors
California
$346K -$4.36M -2 Closed
TCIM
15
TIAA CREF Investment Management
New York
$337K – – –
Mackenzie Financial
16
Mackenzie Financial
Ontario, Canada
$333K – – –
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$302K – – –
BCM
18
Bridgeway Capital Management
Texas
$275K – – –
LPL Financial
19
LPL Financial
California
$259K – – –
Bank of New York Mellon
20
Bank of New York Mellon
New York
$244K – – –
COPPSERS
21
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$237K – – –
Fifth Third Bancorp
22
Fifth Third Bancorp
Ohio
$233K – – –
Wells Fargo
23
Wells Fargo
California
$230K – – –
PP
24
Paloma Partners
Connecticut
$206K – – –
LP
25
LMR Partners
United Kingdom
$174K – – –
1
2 3 4

PALI Hedge Fund Activity: Q2 2015 in Review

9 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q2 2015, worth a combined $35.5M — down 8.4% from $38.8M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new PALI positions and 2 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Credit Suisse, opening a new position worth an estimated $2.18M. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $4.36M sold.

  • 9 institutional investors held Palisade Bio (PALI) as of Q2 2015, up from 7 in Q1 2015.
  • Funds reported $35.5M of Palisade Bio stock for Q2 2015, down 8.4% quarter-over-quarter.
  • 4 funds opened new Palisade Bio positions in Q2 2015 and 2 closed out, a net change of +2 holders.
  • The largest Palisade Bio buyer in Q2 2015 was Credit Suisse, an estimated $2.18M added.
  • The largest Palisade Bio seller in Q2 2015 was BlackRock Fund Advisors, an estimated $4.36M sold.

Based on aggregated 13F filings for Q2 2015.